Table 3 Survival rates at 5-year
7th edition | 8th edition | ||||||
|---|---|---|---|---|---|---|---|
T category | OS | DFS | LRRFS | T category | OS | DFS | LRRFS |
T1 | 95.1% | 91.5% | 98.8% | T1 | 95.0% | 91.3% | 98.7% |
T2 | 93.5% | 90.1% | 95.1% | T2 | 93.7% | 88.8% | 95.2% |
T3 | 84.6% | 76.6% | 89.6% | T3 | 81.4% | 72.6% | 91.4% |
T4 | 69.5% | 58.2% | 83.3% | T4 | 56.5% | 50.0% | 78.5% |
N category | OS | DFS | DMFS | N category | OS | DFS | DMFS |
N0 | 97.0% | 97.0% | 98.0% | N0 | 97.0% | 97.0% | 98.0% |
N1 | 84.4% | 75.3% | 92.3% | N1 | 87.8% | 75.3% | 92.3% |
N2 | 84.4% | 75.8% | 88.4% | N2 | 84.8% | 77.1% | 89.0% |
N3a | 75.0% | 75.0% | 75.0% | N3 | 72.3% | 61.5% | 78.5% |
N3b | 71.1% | 50.5% | 74.8% | ||||
Clinical stage | OS | DFS | Clinical stage | OS | DFS | ||
I | 100.0% | 100.0% | I | 100.0% | 100.0% | ||
II | 98.0% | 98.0% | II | 98.0% | 98.0% | ||
III | 91.3% | 88.7% | III | 88.0% | 78.9% | ||
IVA | 74.6% | 70.2% | IVA | 73.4% | 61.5% | ||
IVB | 74.6% | 72.2% | |||||